The Case for Microbiome Manipulation in the Treatment of Inflammatory Bowel disease (IBD) 

Gut Microbiota have long been suspected of playing a role in the pathogenesis of Inflammatory Bowel Disease (IBD). Emerging data, coupled with advancements in high-throughput sequencing, now highlight its potential in IBD treatment as well.
Dr. Lea Ann Chen
Director, Inflammatory Bowel Disease Translational Research
Assistant Professor of Medicine
Rutgers Robert Wood Johnson Medical School
May 5, 2021